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ABSTRACT
Human adenoviruses (Ads), members of the family adenoviridae,
are medium-sized DNA viruses which have been used as valuable
research tools for the study of RNA processing, oncogenic
transformation, and for the development of viral vectors for use in gene
delivery and immunization technology. The left 12% of the linear Ad
genollle codes for products which are necessary for the efficient
replication of the virus, as well as being responsible for the forlllation of
tumors in animallllodels. The establishlllent of the 293 cell line, by
immortalization of human embryonic kidney cells with th~ E1 region of
Ad type S (AdS), has facilitated extensive manipulation of the Ads and
the development of recombinant Ad vectors.
The study of bovine adenoviruses (BAVs), which cause mild
respiratory and gastrointestinal infections in cattle has, on the other
hand, been limited primarily to that of infectivity, immunology and
clinicallllanifestations. As a result, any potential as gene delivery
vehicles has not yet been realized. Continued research into the
molecular biolo~gy of BAVs and the development of recolllbinant vectors
would benefit from the development of a cell line analogous to that of
the 293 cells.
In an attelllpt to establish such a cell line, the recombinant
plaslllid pKC-neo was constructed, containing the left 0-19.7% of the
BAV type 3 (BAV3) genome, and the selectable marker for resistance to
the aminoglycoside G418, a neomycin derivative. The plasmid construct
was then used to transfect both the Madin-Darby bovine kidney (MDBK)
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cell line and primary bovine lung cells, after which G418-resistant foci
were selected for analysis. Two cell lines, E61 (MDBK) and E24 (primary
lung), were subsequently selected and analysed for DNA content,
revealing the presence of the pKC-neo sequences in their respective
genomes. In addition, BAV3 RNA transcripts were detected in the E61
cells. Although the presence of E1 products has yet to be confirmed in
both cell lines, the E24 cells exhibit a phenotype characteristic of partial
transformation by E1. The apparent immortalization of the primary
lung cells will permit exploitation of their ability to take up exogenous
DNA at high efficiency.
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CHAPTER 1: INTRODUCTION
Adenoviruses are medium-sized, non-enveloped DNA VIruses,
which cause mild respiratory and gastrointestinal disorders in a
variety of hosts (Straus, 1984). The adenovirus genome consists of a
single molecule of double-stranded (ds) DNA, having an average
length of 36,000 base-pairs (bp), depending on the particular
serotype, a classification based on several criteria, such as the
agglutination of rat erythrocytes (Hierholzer, 1973). Six early (E) and
five late (L) transcriptional units are distributed over both strands of
the genome, the E regions coding primarily for regulatory proteins,
and the L regions coding for structural proteins of the viral capsid.
The E and L designations refer to the time of expression, either
before or following replication of the viral genome.
The left 12% of the human adenovirus (Ad) genome codes for
products which are responsible for the efficient transcription of the
other viral regions, as well as for oncogenic transformation in
experimental systems. This region is designated El, being the first
expressed during infection. The products of El exert their effects
through association with cellular transcription factors, in a
mechanism of trans-regulation, making this region a valuable tool for
studying the regulation of transcription in eukaryotic cells.
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The trans-regulatory nature of the E1 products has been
exploited to facilitate the replication of Ad mutants having deletions
in their E1 sequences, which are otherwise unable to replicate In
.most mammalian cells. Rescue of these mutants has been
accomplished by supplying the E1 products from the expressIon of E1
sequences which have been inserted into the genome of the host cell.
In 1986, Raj-Ahmad and Graham reported the first of such
experiments, in the construction of an Ad type 5 (Ad5) mutant
having deletions In E1 and another early region, E3 (Haj-Ahmad and
Graham, 1986). The Ad5 mutant of Haj-Ahmad and Graham was
rescued in the 293 cell line, which contains and expresses the E 1
region of Ad5, resulting from the immortalization of hu~an
embryonic kidney cells with this same region (Graham et. al., 1977).
Bovine adenoviruses (BAVs) are a subgroup of adenoviruses
which infect bovine and ovine species, but have not been studied to
nearly the same extent as the human Ads. As a result, any potential
for clinical applications has not yet been realized. The development
of a system for the manipulation and study of BAVs and BAV
vectors, analogous to the human Ad system, necessitates the
establishment 'of a cell line analogous to that of 293 cells, but
expressing the E1 products of a BAV.
The development of a recombinant BAV vector has appeal, not
only for use in veterinary medicine, but for the potential In human
gene therapy and immunization, eliminating the pitfalls of
undesirable reversion, through recombination, to a wild-type (wt)
state, which might result in symptomatic infections and the
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inappropriate delivery of genes to non-target tissues, a concern In
the case of the human Ad vectors.
The construction of a cell line analogous to 293 cells is
described here, based on the .. introduction of BAV type 3 (BAV3) El
sequences into both the Madin-Darby Bovine Kidney (MDBK) cell line,
an established cell line, as well as into primary bovine lung cells.
The strategy behind the construction of the novel cell line consisted
of three main elements. The first goal was the insertion of the BAV3
sequences into the established MDBK cell line. The second goal
involved an attempt to immortalize primary cells using the putative
transforming properties of the BAV3 El region, properties which are
predicted based on results with the analogous El region of the
human Ads. The third goal, pending success of the second, was the
establishment of a new cell line having pr~perties desirable for BAV
research in general. Since there have been relatively few detailed
studies of the biological properties of BAVs, BAV research could
benefit from such a cell line.
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CHAPTER 2: LITERATURE REVIEW
2.1 The adenovirus genome
The adenovirus, a medium-sized DNA VIrus, IS a member of the
family adenoviridae, which is subdivided into aviadenoviruses and
mastadenoviruses (figure 1). Animal adenoviruses are responsible
for mild infections of the upper respiratory and gastrointestinal
tracts of humans and other animals (Straus, 1984), with' the human
subgroup (Ads) first being isolated from adenoidal tissue of children
suffering from upper respiratory infections (Rowe et. al., 1953). The
bovine adenoviruses (BAVs) are a subgroup of the animal
adenoviruses, and although much of the following discussion
concerns the extensively studied human subgroup, the basic features
of the virus and its genome are shared by the BAVs, which will be
discussed in more detail in a later section.
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Figure 1. Members of the family Adenoviridae.
The Ads contain a linear, double-stranded molecule of DNA,
having an average length of 36,000 bp, depending on the particular
serotype. Conventional map's of the Ad genome are divided into 100
increments, or map units (mu), each unit corresponding from
approximately 325 to 360 bp in length, depending on the serotype
(figure 2). The two strands of the genome are labelled, by
convention, right (r) and left (1), pertaining to the direction of
transcription from the numerous coding regions. These regions are
differentiated by the relative times at which they are transcribed
during infection. Four early (E) regions, coding for regulatory
proteins, are transcribed from six promoters, located on both the r
and the I strands. A single late promoter, the major late promoter
(MLP), drives transcription of all five late (L) regions, which code for
the structural proteins of the viral capsid, on the r strand. The
coding regions are flanked by inverted terminal repeats (ITRs) of
100 to 200 bp, which contain the origins of replication and consensus
sequences recognized by nuclear factors, such as NFIII.
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Figure 2. Conventional map of the Ad2 genome. One map unit
corresponds to approximately 360 bp. The mRNA and protein
products are listed above and below the map, relative to the
locations on the genome from which they are expressed. (arrows)
mRNA; ([]) proIl}oters; (E,L) transcriptional units (from Joklik, 1988).
2.2 Early region 1
The first region to be expressed during infection, El, is
required for the efficient transcription of the other early genes and
thus required for initiation of viral replication (Nevins, 1981; Berk,
1986). El of Ad2 and Ad5 is divided into two transcription units,
EIA (1.3-4.5 mu) and EIB (4.6-11.2 mu) (Grand, 1987; Nevins, 1987).
Both EIA and EIB code for several mRNA and protein products,
where transcripts are labelled according to their sedimentation
coefficient (S). The mRNA transcription products of EIA share
common 5' and 3' ends, and are generated by alternative splicing of
the primary RNA transcripts. Similarly, the EIB transcripts share 3'
sequences, and are also generated through alternative splicing, as
well as the use of different reading frames ..
The EIA codes for 5 mRNA products, the 13S, 12S, lIS, lOS and
9S transcripts (figure 3). The EIA mRNA can be detected as early as
30 minutes follwing infection (Berk et. al., 1979), but only the 12S
and 13S products accumulate at this stage. The 9S mRNA appears at
late stages of infection (Berk and Sharp, 1978), and, along with the
lOS and 11 S transcripts, codes for products which have not been well
characterized. In Ad2 anq Ad5, the 12S and 13S transcripts code for
products of 243 and 289 amIno acids, respectively, designated 243R
and 289R (Perricaudet et. al., 1979; Ricciardi et. al., 1981; Gaynor et.
al., 1982). These proteins are identical except for a stretch of 46
amino acids, present in the 289R product, from residue 140 to
residue 188, but absent in the 243R product (Moran and Mathews,
1987). This unique 46 amino acid sequence constitutes one of three
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Figure 3. Splicing events and gene products from the E1A region of
Ad2. The solid line at the top of the figure represents the Ad2
genome from nucleotide 500 (1.3mu) to nucleotide 1600 (4.5mu).
The RNA transcripts are shown as solid lines, labelled according to
the sedimentation coefficient (S) of the mRNA products. Proteins are
shown as boxes, with the ·number corresponding to the number of
amino acid residues. Splicing events are shown as angled lines.
(from Boulanger and Blair, 1991).
1 0
regIons which are highly conserved among most adenovirus
serotypes, designated CR (conserved region) 1, CR2 and CR3, which
are responsible for various effects, described in figure 4 (Lillie et. al,
1987). The E1A products are diffusible trans-activators (Berk, 1986;
Jones et. al., 1988; Nevins, 1987), and it is the unique region, CR3,
which is responsible for this function, and therefore for the
expression of all other adenoviral genes (Moran and Mathews, 1987).
Genetic analysis, using deletions and point mutations in the
E1A region, has shown that the 243R and 289R E1A proteins
stimulate transcription from all of the early promoters, as well as
from the E1A promoter itself. The transcription from th~ E1A
promoter, however, is stimulated by only 5 fold, as compared to the
other promoters, which are stimulated 50 f~ld by the E1A proteins
(Berk et. al., 1979; Jones and Shenk, 1979; Osborne et. al., 1984).. The
EIA promoter is also under partial control of the EIB region, but it is
not clear if this is due to trans-regulation or to a cis effect (Barker
and Berk, 1987; Grand, 1987; Senear and Lewis, 1986), although
expression of EIA is greatly enhanced in transfection experiments
when encoded on the same plasmid as EIB, as opposed to coinfection
with a separate plasmid c~rrying EIB (Jochemsen et. al., 1987).
The EIA products stimulate transcription from class II and
class III promoters, which are transcribed by RNA polymerase II and
RNA polymerase III, respectively (Leong and Berk, 1986; Berger and
Folk, 1985; Berk, 1986) Transactivation by the 289R E 1A product
can be attributed to interactions with the TATA-binding protein
(TBP), a component of the transcription initiation complex TFIID,
40 80 121 140 188 289
Nuclear
localization
1 1
Figure 4. Regulatory regions of the 289R product of EIA.
Conserved regions and degree of homology between several Ad
serotypes are shown in hatched boxes. Amino acid positions are
indicated above the bar, and the function of each region below the
bar. (from Moran and Mathews, 1987).
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demonstrated by retention of TBP on EIA affinity columns (Horikoshi
et. al., 1991). In addition, transcription from EIB, which is
dependent on EIA expression, is diminished if the TATA box within
the upstream regulatory regions is interrupted (Wu et. al., 1987).
The CR3 appears to contain the TBP-binding motif, since deletions or
mutations in this region inhibits formation of the TBP-EIA complex
(Lee et. al., 1991). Some mutations, however, do not disturb the
complex, but affect transactivation, suggesting that other proteins are
required for the complete transactivation events. There are
suggestions that EIA might in fact form a bridge between ATF-2 (a
DNA-binding transcription factor) and TBP (Lee el. al., 1991).
EIA has been found to act synergistically with cyclic AMP
(cAMP), a second-messenger of signal-tra~sduction pathways, which
regulates gene expression by a cascade of events involving protein
kinases (Engel et. al., 1988). cAMP responsIve elements (CRE) have
been located in upstream regulatory sequences of cellular and viral
genes, and transcriptional activation of EIA, EIB and E4 occurs in the
presence of cAMP (Engel et. al., 1988). In addition, activating
transcription factor (ATF) binds to and activates the CRE in the
promoters of EIA, E3 an~ E2 (Hurst and Jones, 1987; Leza and
Hearing, 1989; Lin and Green, 1988). The synergistic effect of EIA
and cAMP induce the DNA-binding activity of another cellular
transcription factor, AP-l (Muller et. al., 1989), which recognIzes the
CRE and AFT consensus sequences (Angel et. al., 1987), suggesting a
role in transactivation of viral genes. Although EIA and cAMP act
synergistically, both resulting in greater induction of transcription
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than with either inducer alone (Engel et. al., 1988), they act by
different pathways (Leza and Hearing, 1989).
The cellular transcription factors E2F and E4F, discovered by
their ability to bind to elements of the E2 and E4 promoters, are also
stimulated by the products of E1A (Reichel et. al., 1988;
Raychaudhuri et. al., 1987). This activation, which results In a
dramatic increase in the DNA-binding activity of both factors (Reichel
et. al., 1987), may be, however, an indirect consequence of the
presence of EIA products, and is more directly associated with a
product of another early region, E4 (Neill et. al., 1990).
Transcription from the EIB region produces 5 mRNA speCIes,
the 22S, 13S, 14S, 14.5S and 9S transcripts (figure 5). The
overlapping 22S, 13S, 14S and 14.5S products are transcribed from a
common promoter, which is activated by the. EIA products (Dery et.
al., 1987), and are generated by alternative splicing of a common
RNA precursor (Pettersson et. al., 1983). The 9S mRNA is transcribed
from an independent promoter, and is expressed 6-8 hours after
infection, coding for a structural component of the viral capsid
(Boulanger et. al., 1979).
Two protein products, of 19kDa (pI9) and 55kDa (p55), are
produced from the 22S EIB transcript, using AUG codons from
different reading frames (Bos et. al, 1981). The other mRNAs, except
for the 9S transcript, also code for the same p 19 product, resulting in
the accumulation of this protein during infection (Boulanger and
Blair, 1991). The role of p19 in the infectious cycle seems to be the
maintenance of the integrity of viral and cellular DNA (Stillman,
1986), and thereby indirectly increasing trancription from newly
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Figure 5. Splicing events and gene products from the E1B region of
Ad2. The solid line at the top of the figure represents the Ad2
genome from 4.6 mu to 11.2 fiU. The RNA transcripts are shown as
solid lines, labelled according to the sedimentation coefficient (5) of
the mRNA products. Proteins are shown as boxes, and are labelled
according to their molecular weight (kDa), from p9 (9kDa) to p55
(kDa). Splicing events are .shown as angled lines. (from Boulanger
and Blair, 1991).
1 5
introduced viral DNA (Herrmann and Mathews, 1989), perhaps by
inhibition of a cellular nuclease activity at the low pH characteristic
of Ad infections (D'Halluin et. al., 1985). The EIB p19 also stimulates
expression from early Ad promoters, including EIA (Herrman et. al.,
1987; Senear and Lewis, 1986).
The p55 protein also has a necessary role for the VIrus life-
cycle. Mutations in p55 have been associated with defective growth
and delayed replication of viral DNA (Stillman, 1986). The activity of
p55 appears to be required for shut-off of cellular DNA synthesis, as
well as for efficient viral DNA replication and the maturation of
mRNAs expressed from the late regIons. This latter suggestion comes
from mutants of p55 which are defective for the production of
structural capsid proteins. The defect appears to lie at a point
between the completion of transcription an~ transport of the mRNA
across the nuclear membrane (Babiss et. al., 1985; Barker and Berk,
1987). This p55 function seems to result from a complex with the
p34 protein product of E4, since mutations in the p34 open-reading
frame (ORF) results in low levels of viral mRNA in the cytoplasm and
reduced shut-off of cellular protein synthesis, effects observed in the
presence of p55 mutations (Halbert et. al., 1985).
The interaction of t~e· El products with cellular factors
involved in the regulation ·of the cell cycle has implications which go
beyond the regulation of viral replication. In particular
circumstances, E1 products can induce changes in cellular pathways
and, in turn, alter the phenotype of the cell. This property has
placed the Ads into a special group of viruses, those responsible for
the formation of some tumors.
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2.3 Oncogenic transformation and El
Ads are members of the DNA tumor viruses, a group which also
includes the polyomaviruses-, hepadnaviruses, papillomaviruses,
herpesviruses and poxviruses. These viruses are capable of
conferring phenotypic changes in mammalian cells, giving them
characteristics of tumor cells, and have been found to be associated
with tumor formation in whole animals.
Cells which have been phenotypically altered in such a way are
said to have been transformed. Transformed cells have
characteristic growth properties and morphological features which
distinguish them from their normal counterparts. The oncogenic
transformation of mammalian cells is a two-stage process (Land et.
al., 1983). The first stage is the establishment of immortalization,
resulting in cells which are capable of indefinite growth in cultur~,
presumably due to the deletion or mutation of one or more
senescence genes, or a mechanism which overrides the action of the
scenescence gene(s) (Pereira-Smith and Smith, 1988). Such cells are
commonly used as research· tools, since their growth is not limited by
the natural constraints imposed on primary cell cultures, which have
a finite life-span of 20-10~ ·generations (Freshney, 1994). All of
these cell lines have resulted from either spontaneous or induced
immortalization of normal, healthy cells.
The second stage of oncogenic transformation involves the
aquisition of growth characteristics and morphological features which
are not associated with normal cells, nor are they typical of
immortalized cells. These properties include a reduction In growth
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serum requirements, the loss of contact inhibition, decreased
anchorage dependence of growth, as well as changes on the cell
surface, in the cytoskeleton, and In the extracellular matrix (Bowen-
Pope et. ai., 1984; Freshney,J 1994; Topp et. al., 1981). Transformed
cells may exhibit any combination of these properties, but do not
necessarily display all of them (Topp et. al., 1981).
In all cases of transformation, whether induced by such diverse
sources as a virus, a chemical carcinogen or radiation, the
fundamental change is of a genetic nature. Genes which underly the
events of oncogenesis, oncogenes, may be introduced into the cell as
foreign DNA or, if already present in the cell, may be the target of
mutation.
The introduction of oncogenes is the most common mechanism
of transformation by tumor viruses. In the .case of RNA viruses,
specifically retroviruses, the oncogene is an altered copy of a normal
cellular counterpart, or proto-oncogene. This phenomenon raises
questions concerning the origin of these oncogenes, since their
existence in such diverse genomes as those of animals and viruses
implies that one had aquired a copy from the other, with the
transmission from animal to virus being the favoured explanation,
SInce these genes have no apparent role in the retroviral genome.
The mutated form of the cellular proto-oncogene carried in a
retrovirus disrupts the normal events of cell-cycle control when
introduced into the target genome. The discovery of the retrovirus
oncogenes has, as a result, led to the identification of the cellular
homologues, and the delineation of the respective functions in the
cell. Some of these oncogenes are listed in table 1, along with the
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function of the cellular proto-oncogenes, the source of the VIrus and
the associated tumors.
The genes delivered by DNA tumor VIruses, on the other hand,
do not have homologues normally shared by the cell, but are genuine
viral genes. Among these viruses, the Ads have been extensively
studied in terms of their oncogenes, particulary since the discovery
of the oncogenic potential of Ad12 in 1962 (Trentin et. al., 1962), a
discovery which propelled Ads into the forefront of molecular
biological research, with the discovery of RNA splicing being among
the resulting major advancements (Berget et. al., 1977; Chow et. al.,
1977). One of the observations emerging from Ad-mediated
oncogenic research was that DNA virus oncogenes exert their effect
through interference with normal cellular pathways, as opposed to
retroviral oncogenes, which are integral parts of those pathways.
Although tumors associated with Ad infections have never
been observed in nature, Ads are capable of transforming cells which
do not support productive infections, as was the case in the initial
1962 discovery, whereby Ad 12 was responsible for tumor formation
in newborn hamsters (Trentin et. al., 1962). Such non-permissive
cells do not facilitate productive lytic cycles for particular Ad groups,
as a result of a "block to the late stages of infection (Doerfler, 1991).
Consequently, non-permissive or abortive infection may result in the
Table 1. Sources and functions of retroviral oncogenes, and their
associated tumors (from Alberts et. al., 1994).
19
Oncogene Proto-oncogene Funcdon Source ofVlnls Vlnls-Induced Tumor
abl protein kinase (tyrosine) mouse pre-B-cellieukemia
cat sarcoma
erb-B protein kinase (tyrosine): chicken erythroleukemia,
epidermal growth factor (EGFJ fibrosarcoma
receptor
les protein kinase (tyrosine) cat/chicken sarcoma
frns protein kinase (tyrosine): cat sarcoma
macrophage colony-stimulating
factor (M-CSF) receptor
los } products associate to form mouse osteosarcomajun AP-l gene regulatory protein chicken fibrosarcoma
kit protein ldnase (tyrosine): cat sarcoma
Steel factor receptor
ral protein ldnase (serine/threonine) chicken/ sarcoma
activated by Ras mouse
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capable of immortalizing cells in culture, the lack of oncogenicity in
whole animals might be due to a mechanis'm independent of the
immortalizing and transforming functions. In Adl2-transformed
cells there is a down-regulation of the products of the major
histocompatibility complex (MHC) (Eager eta al., 1985; Schreier eta al.,
1983; Vasarada eta al., 1986), which might enable these cells to
escape cytotoxic T lymphocyte (CTL) surveillance, and result in their
tumorigenicity (Tanaka eta al., 1985; Bernards eta al., 1983). This
event might be mediated by a 19kDa product of another early region,
E3, which was shown to complex with MHC class 1 in the endo'plasmic
reticulum (Kvist eta al., 1978), as well as a 14.7kDa product from the
same region, which prevents lysis by tumor necrosis fac,tor (TNF)
(Gooding eta al., 1988). Differential degrees of sequestration by these
E3 products between Ad12 and Ads2 and' ~ may explain the
differences in tumorigenicity.
Another explanation for the different degrees of tumorigenicity
among Ad groups may be differences in viral functions involved in
inserting the viral DNA into the host cell, in such a way that it can be
efficiently expressed (Rowe and Graham, 1983). This explanation
suggests that the degree of oncogenicity is independent of the source
of the E1 region, once it is being expressed.
Expression of both EIA and EIB is required for complete
transformation of primary cells. The products of EIA are alone
capable of immortalizing primary cells in culture, being both
necessary and sufficient for this event (Houweling eta al., 1980) and,
in the presence of other oncogenes, such as ras or the EIB products,
can result' in transformation (Branton eta al., 1985; Ruley, 1983; Zerler
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integration of viral DNA sequences into the host-cell genome. This
integration event, as in the case of Ad 12 infection of the rodent cells,
may result in oncogenic transformation.
Cells which have been transformed by this mechanism contain,
as a minimum, the left 0-12% of the Ad genome stably integrated
into their own genome, and constituitively express the products of
the EIA and EIB regions (Graham and van der Eb, 1973; Gallimore et.
al., 1985). This observation, consistent in all cases of transformation
by Ads, implicated the El region as that responsible for the
transformation event. The ability of the E1 region alone, as the only
input DNA, to transform cells which are otherwise permissive to Ad
infection is consistent with the notion that integration of the Ad·
genome, as would be the fate in the case 'of an abortive or non-
permissive infection, is the requirement for transformation (Gr'lham
et. al., 1977).
The products of E1 are recognized by serum antibodies from
animals bearing tumors of adenoviral origin (Matsuo et. al., 1982).
As a result, they are referred to as tumor antigens, or T-antigens, a
term which is al.so used to describe. similar products from other
tumor viruses, such as th~ large-T (LT) antigen of Simian virus 40
(SV40).
The various serotypes of the human Ads are not equally
oncogenic, and are classified based on their ability to form tumors in
newborn rodents (Graham, 1984). In contrast to the highly
oncogenic Ad12, Ad2 and Ad5 are classified as non-oncog,enic in
vivo. Since the El region of both Ad2 and Ad5 are nonetheless
2 1
capable of immortalizing cells in culture, the lack of oncogenicity In
whole animals might be due to a mechanism independent of the
immortalizing and transforming functions. In Ad 12-transformed
cells there is a down-regula~ion of the products of the major
histocompatibility complex (MHC) (Eager et. al., 1985; Schreier et. al.,
1983; Vasarada et. al., 1986), which might enable these cells to
escape cytotoxic T lymphocyte (CTL) surveillance, and result in their
tumorigenicity (Tanaka et. al., 1985; Bernards et. al., 1983). This
event might be mediated by a 19kDa product of another early region,
E3, which was shown to complex with MHC class 1 in the endoplasmic
reticulum (Kvist et. al., 1978), as well as a 14.7kDa product from the
same region, which prevents lysis by tumor necrosis factor (TNF)
(Gooding et. al., 1988). Differential degrees of sequestration by these
E3 products between Ad12 and Ads2 and- 5 may explain the
differences in tumorigenicity.
Another explanation for the different degrees of tumorigenicity
among Ad groups may be differences in viral functions involved in
inserting the viral DNA into the host cell, in such a way that it can be
efficiently expressed (Row~ and Graham, 1983). This explanation
suggests that the degree of oncogenicity is independent of the source
of the E1 region, once it is being expressed.
Expression of both E1A and EIB is required for complete
transformation of primary cells. The products of EIA are alone
capable of immortalizing primary cells in culture, being both
necessary and sufficient for this event (Houweling et. al., 1980) and,
in the presence of other oncogenes, such as ras or the EIB products,
can result in transformation (Branton et. al., 1985; Ruley, 1983; Zerler
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et. al., 1986). The specific contributions of these regIons to
immortalization and transformation are shown in figure 6, and a
summary of their overall participation in viral replication and
cellular transformation is presented in figure 7.
The transforming properties of the E1 region have been
mapped by deletion analysis to CR1 and CR2 of the 289R and 243R
products, between amino acids 40 to 80, and 121 to 139
(Kuppuswamy and Chinnadurai, 1987; Lillie et. al., 1987; Moran and
Zerler, 1988). These regions contain sites for interactions with a
member of a group of cellular proteins known as tumor-suppressors,
or anti-oncogenes. The deletion or inactivation of the tumor-
suppressor genes and their products are associated with many
human tumors (Lee et. al., 1988). The association of E1A products
with tumor-suppressors has therefore been implicated as the
mechanism behind the oncogenic activities of E1A.
One of the predominant tumor-suppressor targets of the E1A
proteins is the product of the retinoblastoma-susceptibility gene
(RB). Cells which lack functional RB products undergo tranformation,
underlying the development- of familial retinoblastoma. This anti-
oncogenic product, pI 05-RB, has been found to be physically
associated with the E1A proteins in vitro and in vivo (Egan et. al,
1989; Whyte et. al., 1988).- One of the cellular targets of p105-RB IS
the cellular transcription factor E2F, which controls the transcription
of several cellular proliferation genes (Nevins, 1992). Association of
p105-RB with E2F regulates progression through G1, by exerting
negative control on E2F (Schwartz et. al., 1993). This p105-RB:E2F
complex is disrupted by the E1A products in vitro, by direct
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Figure 6. Structure and functions of the oncogenic regions ElA and
EIB of Ad2. The solid line in the middle of the figure represents the
Ad2 genome from 0-12 mu.· The top half of the figure shows the
RNA (solid lines) and protein (boxes) products of the ElA and EIB
regions. The lower half of the figure describes the contribution of
the particular regions in immortalization and transformation. (from
Graham, 1984).
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replication and cellular transformation. (E) early region.
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interaction between p105-RB and the CRI and 2 domains of the E1A
proteins (Bandara and LaThangue, 1991; Whyte et. al., 1988). This
dissociation event is believed., to result in the release of cell cycle
control by liberation of the E2F transcription factor. The net result,
however, seems to be the prevention of entry into GO in quiescent
cells, rather than the direct, positive induction of proliferation, since
the disruption of the p105-RB:E2F complex by E1A occurs too slowly
to account for the rapid entry into S-phase observed in E1A-
transformed cells (Spitkovsky et. al., 1994; Wang et. al., 1991).
The rapid induction of proliferation by E 1A therefore seems to
be the result of an additional mechanism, one which seems to involve
the cyclins, which induce proliferation through activation of the
cyclin-dependent protein kinase (cdk) gene. family products (Pines,
1993). Regulation of cell-cycle progression by the cyclins is
demonstrated by overexpression of any of the cyclin genes A, D 1 or
E, which can overcome the block to cell division imposed by pRB
(Hinds et. al., 1992), and the observation that overexpression of
cyclins E and D1 can accelerate the G1 phase in fibroblasts (Quelle et.
al., 1993). Spitkovsky et. ale (1994) demonstrated that expression of
both cyclins A and E are induced by E1A, showing that E1A-
dependent S-phase entry is correlated to modulation of cyclin gene
expression, and that the disruption of the p105-RB:E2F complex may
not be required for the onset of DNA synthesis in quiescent rat
fibroblasts. The control exerted by E1A through the cyclins reveals
the ability of E1A to mimick serum-dependent cell-cycle activation.
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The requirement for both EIA and EIB expression for complete
transformation may be attributed to both the p19 and p55 products
of EIB. Clues into the role of p19 in cellular transformation arise
from the cellular localization of this product. The p19k protein has
been found in such diverse locations as the nuclear envelope and the
endoplasmic reticulum (White et. al., 1984; Blair-Zajdel et. al., 1985),
as well as associated with the plasma membrane (Persson et. al.,
1982; Smith et. al., 1989). In addition, this protein has also been
found to be associated with the vimentin-containing intermediate
filament network (White and Cipriani, 1989, 1990). It is this last
observation that implicates p19 in contributing to the transformed
phenotype, in particular, the anchorage-independent growth
characteristic of the transformed cells, by disruption of the
intermediate filament network. In the case of tumor formation in
whole animals, the E1B P19 product protects the infected cell against
the cytotoxic effects of tumor-necrosis factor (TNF), reminiscent of
the role of E3, allowing oncogenesis to proceed (White et. al, 1992).
The role of EIB p55 in transformation may be analogous to that
of EIA, since the protein can form a complex with the tumor-
suppressor product p53, resulting in a release of growth control
(Finlay et. al., 1989; Lan~ and Benchimol, 1990). In addition, there
have been suggestions that p55 may function at the level of DNA
integration in a transformed cell (Rowe and Graham, 1983).
The necessity for the role of p55 in transformaton by whole
VIrus was demonstrated by Babiss et. ale (1984) and Graham et. ale
(1977), followed by a demonstration of the requirement for
expression of both P19 and p55 in DNA-mediated transformation,
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which was confirmed by genetic analysis using point-mutations
(Senear and Lewis, 1986; Barker and Berk, 1987). The cooperative
nature of ElA and EIB is a general phenomenon of oncogenes, and IS
not unique to the adenovirus. Oncogenes can be classified into 2
broad groups. The first group, which includes E 1A, are only able to
immortalize primary cells in culture, locking them in a proliferative
mode (Land et. al., 1983). This group also includes products such as
the SV40 LT antigen and those of myc, proteins which are generally
localized in the nucleus. Structural studies have, in fact, revealed a
similarity between the products of E 1A and those of myc and my b
(McLachlan and Boswell, 1985; Ralston and Bishop, 1983). The
second group consists of cytoplasmic or membr~ne-bound proteins,
such as the ras products, polyomavirus mT antigen and the
membrane-associated p 19 E 1B protein. ~hese proteins are
responsible for completion of the transformation events (Land et. al.,
1983; Byrd et. al., 1988; Kelekar and Cole, 1987; Ruley, 1983). The
complementary nature of transformation by these elements IS
particulary apparent in the ability of the polyomavirus mT antigen
and the products of ras to' substitute for EIB in transformation by
EIA (Ruley, 1983).
2.4 Adenovirus vectors
The mechanism of transformation by the adenovirus has been
a topic of extensive research, contributing to a detailed
understanding of some of the adenovirus products. In addition, the
adenovirus, having a relatively simple genome, has proved to be an
invaluable research tool to study the events which control gene
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expreSSIon In mammalian cells. As a result, an understanding of the
structural and functional aspects of the adenovirus genome
eventually, and perhaps inevitably, led to the manipulation of the
adenovirus for exploitation .,as a vector for the delivery and
expressIon of foreign genes in mammalian cells.
Adenovirus vectors are currently being used In pre-clinical
trials of gene therapy for the treatment of cystic fibrosis (Crystal et.
al., 1994). The adenovirus is an attractive vector for such an ailment,
because of its tropism for tissues of the respiratory and the
gastrointestinal tract, which, in the case of cystic fibrosis, facilitates
delivery to the patient by aerosol. The adenovirus is advantageous
as a vector because of its ability to express gene~ in non-dividing
cells, not only in cells such as those just mentioned, but also in the
liver (Jaffe et. al., 1992), blood vessels (Lemarchand et. al., 1993),
muscle (Stratford-Perricaudet et. al., 1992) and brain (Le Galle La
Salle et. al., 1993). This advantage is in contrast to retrovirus
vectors, which are quite effective, but only for rapidly dividing cells
such as stem cells which, incidentally, must be removed from the
patient and treated In culture, followed by reintroduction to the bone
marrow. As with the case in the cystic fibrosis trials, the adenovirus
can be deli vered to the w·hole animal, intravenously or otherwise.
The possibility of rescuing a virus from mammalian cells, using
an input merely of plasmid DNA, was realized in 1983 by Kathleen
Berkner and Philip Sharp (Berkner and Sharp, 1983). When
plasmids containing overlapping fragments of the AdS genome,
together encompassing the entire genome, were cotransfected into a
human embryonic cell line (the 293 cell line), the result was the
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production of wt VIrus. The results of the experiment opened the
door for the construction and rescue of adenovirus mutants, whereby
regions of the genome could be manipulated in a convenient plasmid
form, followed by reconstruction in vivo.
The work of Berkner and Sharp was complemented by Haj-
Ahmad and Graham, who used this method of homologous
recombination and viral rescue to construct the first adenovirus
mutant used to carry and express foreign genes in mammalian cells.
Indeed, the adenovirus vector developed by Haj-Ahmad and Graham
has been used extensively since their initial report in 1986 (Haj-
Ahmad and Graham, 1986), to express exogenous genes In numerous
animal and cellular models, and is currently being used in clinical
trials for the delivery of the cystic fibrosis transmembrane
regulatory (CFTR) protein to the respiratory tract of individuals
suffering from cystic fibrosis, as previously mentioned (Crystal et. al.,
1994) .
The double-deletion mutant of Raj-Ahmad and Graham, dIE 1,3,
was constructed to accomodate the packaging of additional DNA into
the viral genome, since wt Ad can package only up to 105% of its
genome (Ghosh-Choudhury et. al., 1986), or an additional 2 kilobases
(kb) of DNA. The mutant contained deletions in both E1 and E3,
eliminating 5.5 kbp of the .genome, and making room for an
additional 7.5 kbp of exogenous DNA (Haj-Ahmad and Graham,
1986). The construction of dIE 1,3, using the method of intracellular
recombination, is illustrated in figure 8.
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Figure 8. Construction of the double-deletion Ad5 mutant, dIE 1,3.
(from Raj-Ahmad and Graham, 1986). (A) Deletion of E3 from 78.5 to
84.7 mu, generating dlE3. (B) Deletion of E1 from 1 to 9.2 mu.
dlE1,3 was rescued by recombination between dlE3 and the E1
deletion, in 293 cells (B).
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The choice of regions Eland E3 for the location of the deletions
was based on 1) observations that region E3 is non-essential for viral
growth and replication (involved in downregulation of the immune
response), and 2) the availability of a cell line (293 cells), which
constituitively expressed the products of the El region (Graham et.
al., 1977). Adenoviruses which lack the El region are normally
unable to replicate in a host cell, but by supplying the missing
functions in trans, the 293 cells can accomodate growth of the
deletion-mutants, facilitating their culture.
The removal of the essential E1 region was the means by which
the desired control over the adenovirus infective 4 cycle was
accomplished. The double-deletion mutants were ideally suited for
applications In gene therapy, incapable of lytic infection in the target
tissues.
The deletion of E 1 was placed so as to maXImIze the packaging
capacity, while maintaining the integrity of other essential regions.
The left-most border of the deletion in EI is defined by adenoviral
sequences from 0 to 1 mu, which must be present on the viral
genome (ie. in cis) for replication, and which, therefore, cannot be
supplied by the 293 cell~. These sequences include the left ITR, the
origin of replication, and a signal for encapsidation of complete
virions. The right-most border is limited by the coding region for a
capsid protein (protein IX), which is required for packaging of full-
length genomes (Ghosh-Choudhury et. al., 1986).
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2.5 Bovine adenoviruses
The discussion to this point has been concerned only with the
human adenoviruses. There are, however, adenviridae groups which
infect animal hosts other than humans, as well as those which infect
birds. These non-human adenoviruses have not been studied to
anywhere near the extent of the human subgroups and, as a result,
have not been exploited as viral vectors. The genus mastadenovirus
contains the human Ads, as well as subgroups which infect monkeys,
cattle, pigs, sheep, horses, dogs, goats and mice (Joklik, 1988). The
potential for exploration and manipulation of non-human
adenoviruses is, therefore, large enough to warrant further research.
Of the animal adenoviruses, the bovine ad~noviruses (BAVs)
have been characterized to an extent sufficient to place them in a
position of consideration for manipulation.. In particular, important
regions of the BAV type 3 (BAV3) genome, including the putative
E1A and E1B, as well as E3 of BAV2, have been sequenced and
characterized by the laboratory of Haj-Ahmad (Elgadi et. al., 1993;
Esford and Haj-Ahmad, 1994). BAV3 is a member of the group I
BAVs, of which serotypes ·1, 2 and 9 are the other members. A
second group of BAVs (group II) consists of serotypes 4-8 (Bartha,
1969).
Particular aspects of the E1 sequence of BAV3 suggests that, for
the most part, reading frames of the human Ads have been
conserved (or vice-versa). Features of the BAV3 E1 sequence have
most recently been described by Zheng et. ale (1994). Comparison
with EIA of AdS reveals significant homology between CR3, as well
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as conservation of a consensus sequence important for the
interaction with the pI 05-RB product.
The EIB region of BAV3 contains two open reading frames
(ORFs), with homology to the p 19 and p55 protein-coding regions of
Ad5, and codes for products having predicted sizes of 17.4 and 46.7
kDa. A transcription unit having homology to that coding for pIX lies
downstream of EIB of BAV3, along with regulatory sequences such
as an SP 1 transcriptional factor binding site and a TATA box (Zheng
et. al., 1994).
Since the CR3 is responsible for transactivation, the
conservation of this region between Ad5 and BAV3 suggested that
expression of the E1 region from one virus coule! potentially replace
the functions of the E1 region from the other virus, and facilitate
transcription of the early promoters in the. genome of the other
adenovirus group. This hypothesis was confirmed by coinfection
with an Ad5 mutant, having deletions in EI and E3, and a plasmid
carrying the El region of BAV3. In the report by Zheng et. ale (1994),
the coinfection resulted in induction of the E3 promoter of Ad5 (not
removed during construction of the mutant) by· E 1 of BAV3, as
detected by expression of a B-galactosidase reporter gene inserted In
the place of the deleted ~3 coding region.
The oncogenic potential of both BAV3 and BAV8 has been
demonstrated in newborn hamsters, which developed
undifferentiated sarcomas at the site of inoculation (Darbyshire,
1966; Mohanty, 1971). The oncogenic nature of BAV3, as compared
to the non-oncogenic serotypes BAV 1 and BAV2, is consistent with
the G+C content of the genome. Highly oncogenic Ads typically have
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a lower G+C content than the non-oncogenIc serotypes. In the case of
BAVs, BAV3 has a G+C content of 48%, whereas BAVI and BAV2
contains 62% and 61 % G+C, respectively (Panigrahy et. al., 1977).
The transfoming properties of BAV3, and the structural and
functional similarity between its El region and that of Ad5, suggest
that immortalization of a primary cell culture with the El region of
BAV3, and the subsequent rescue of a BAV3 El-deletion mutant, is
possible.
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2.6 Objectives of this in vestigation
The objectives of this study were:
( 1) To construct a recombinant plasmid contaInIng sequences from
the left end of the BAV3 genome, linked to a drug-resistance
marker for easy selection.
(2) To establish cell lines containing the construct from (1)
inserted into the cellular genome, as candidates for the rescue
of BAV mutants.
(3) To assess any morphological changes which might result from
expression of the BAV3 sequences.
(4 ) To evaluate the utility of any novel cell lines for further
research involving bovine viruses.
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CHAPTER 3: MATERIALS AND METHODS
3.1 Bacterial strains
Escherichia coli (E. coli) strain DH5-alpha (Gibco BRL) was used
for all recombinant plasmid engineering.
3.1.1 Propagation and maintenance of bacteria cultures
Bacteria cultures were grown in Luria broth [LB: 10% Bacto-
tryptone (Difco); 5% Bacto-yeast extract (Difco); 10% NaCI, pH 7]. Cells
were stored at 4°C on LB plates, or in 15% glycerol at -20°C. Selection
for antibiotic resistance was carried out in either 50Jl g/ml ampicillin,
or 100fJ-g/ml kanamycin, or a combination of both.
3.2 DNA ligations
Ligations were carried out at 16°C overnight (blunt ends) or at
room temperature for 2-3 hours (overhanging ends). Ligations were
performed in a ligation buffer supplied by NEB (1 OmM MgCI2; 20mM
dithiothreitol; 50mM Tris; ImM ATP, pH 7.5), using recombinant T4
DNA ligase (NEB).
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3.2.1 Transformation of competent bacteria
Transformations were carried out as described In Sambrook et.
ale (1989). E. coli DH5-alpha cultures were grown to an OD600 of 0.3-
0.4. The culture was then aliquoted into sterile polypropylene tubes
and centrifuged at 1000g (lEC Centra-7R) for 15 minutes at 4°C. The
pellets were then resuspended in 25ml of ice-cold transformation
buffer (75mM CaCI2; 5mM Tris-HCL, pH 7.6) and placed at 4°C
overnight. The tubes were centrifuged as above, and the pellet
resuspended in lml ice-cold transformation buffer. One hundred J.lI
aliquots were used immediately, or stored at -70°C.
Plasmid DNA (l-l0J.lg) was added to the competent cells and
incubated on ice for 30 minutes, with occassional mixing. The cells
were then heat-shocked at 42°C for 45 seconds, and diluted in 900J.lI
SOC medium (2% Bacto-tryptone; 0.5% yeast extract; 10mM NaCI;
2.5mMKCI; 10mM MgCI2; lOmM MgS04; 20mM glucose). One
hundred J.lI aliquots were then plated on LB agar plates containing
the appropriate antibiotic, and incubated overnight at 37°C.
3.3 Small-scale plasmid DNA preparations
Small-scale DNA isolations were carried out according to a
variation of the method de-scribed by Birnboim (1983). Overnight
cultures of transformed bacteria were centrifuged for 30 seconds in a
microcentrifuge (12,OOOg). The resulting pellet was then
resuspended in 100J.lI lysing buffer [lOmM EDTA; 50mM glucose;
25mM Tris-HCI; 2mg/ml lysozyme (Sigma), pH 8.0]. The tube was
incubated for 10 minutes at room temperature, followed by the
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addition of 200JlI alkaline-SDS (0.2N NaOH; 1.0% SDS). After
incubation at room temperature for 10 minutes, 150J.lI of 3M NaAc
(pH4.8) was added, and the sample placed on ice for 15 minutes. The
sample was then centrifuge,d at 12,000g for 5 minutes, and the
supernatant transferred to a fresh tube. The DNA was precipitated
with 2 volumes of ice-cold 95% ethanol, and pelleted by
centrifugation at 12,000g for 3 minutes. Following complete removal
of the ethanol, the pellet was suspended in sterile water or TE buffer
(10mM Tris; 1mM EDTA, pH 7.5).
3.3.1 Large-scale plasmid DNA preparations
Transformed cultures were grown overnight in 500ml of LB at
37°C. The plasmid DNA was extracted as described above for small-
scale preparations, but starting with 10ml lysing buffer, and scaling
up the other solutions proportionately.
3.3.2 CsCI purification of plasmid DNA
Plasmid DNA was purified by ultracentrifugation In esCI uSIng
the procedure described in Sambrook et. ale (1989). DNA from a
large-scale extraction was suspended In water, following the addition
of ethidium bromide to a concentration of 0.8mg/ml, and esCI to
achieve a density of 1.55-1.59g/ml. The solution was centrifuged In
3ml Beckman Quick-Seal centrifuge tubes at 65,000rpm (179,000g),
in a Beckman TL-100 ultramicrocentrifuge (rotor SN1533) for 20
hours at 10oe. After centrifugation, the band of supercoiled plasmid
DNA was extracted with an 18 gauge needle, and transferred to an
Eppendorf tube, where the ethidium bromide was removed by
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extraction with isoamyl alcohol, until the DNA solution was no longer
pink. The DNA was then precipitated with 2 volumes ice-cold
ethanol, following a 3-fold dilution of the solution to dissolve residual
CsCl.
3.3.3 Restriction enzyme digestion and gel electrophoresis
Digestions were carried out at 37°C, from 30 minutes to 16
hours, according to suppliers' specifications. Usually, 1-10J.l,g of DNA
was digested in Ix reaction buffer, supplied by the manufacturer,
containing the appropriate units of restriction enzyme (NEB) and, if
required, bovine serum albumin.
Digests were added to electrophoresis loading buffer (20%
glycerol; 2% SDS; 0.05% bromophenol blue) and fragments were
separated by agarose gel electorphoresis in 0.7-1 % agarose gels, at 1-
10V/cm in TAE buffer (40mM Tris; 20mM acetic acid; 1mM EDTA, pH
8.0). DNA was visualized by staining the gel with 0.5J.l,g/ml EtBr, for
10-30 minutes, followed by illumination on a UV transilluminator.
Gels were photographed with a Polaroid Land camera, with Polaroid
type 57 film. _ The sizes of the DNA fragments were estimated using a
lambda DNA-HindIII digest (NEB) as a molecular weight marker.
3.4 Mammalian cell culture
Mayden-Darby Bovine Kidney cells, E61, E24 and prImary
bovine kidney and lung cells were maintained in Earle's Minimum
Essential Medium, supplemented with 6% Donor Bovine Serum
(Cansera, Rexdale, Ontario), 0.29J.l,g/ml L-glutamine, 0.225% sodium
bicarbonate and 1.5% antibiotic-antimycotic [10,000 units/ml
40
penicillin, 25J.1g/ml amphotericin Band 10,000J.1g streptomycin
(Gibco BRL)]. Cells were maintained at 37°C at constant atmospheric
pressure, in a C02 incubator.
3.4.1 Fetal calf tissue and primary cell culture
Primary bovine lung cells were cultured from tissue excised
from a deceased fetal calf, within 1 hour of being removed from the
cow (Kingma Meat Products Ltd., Wellandport, Ontario). Following
removal of the lungs (as well as kidney and liver), 1cm3 cubes of
tissue were rinsed with iodine and chopped into small pieces in a
sterile culture dish using a scalpel. The tissue was then placed in an
erlenmyer flask containing Ix trypsin, and stirred on a magnetic
stirring plate for a total of 1 hour. Aliquots of 1ml were drawn at 15
minute intervals, and added to 60mm culture dishes. The medium
was changed daily, and the establishment of a cell monolayer was
monitored closely for 2 weeks.
3.5 Mammalian cell transfections
Cells were transfected using both the method of calcium
phosphate precipitation and that utilizing the commercial
polycationic lipid product LIPOFECTAMINETM (Gibco BRL). A series of
conditions were tried in o-rder to optimize the transfection efficiency
but, in general, the procedures were performed as follows. For the
method of calcium phosphate precipitation, DNA was added to 450J.1l
tris-EDTA buffer(pH 7.4) and 50J.11 2.5M CaC12. The mixture was
then added dropwise into 500J.1l HEPES (N -2 hydroxyethyl-
piperazine-N' -2-ethanesulfonic acid) buffer (pH 7.05), while gently
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bubbling the solution with a pasteur pipette. After 20 minutes at
room temperature, the solution was added to the cells, without
removing the medium. Cells were seeded at densities of
5xl05/60mm culture dish, ~or 1.5xl06/lOOmm culture dish, 24
hours prior to transfections. After 4-24 hours incubation, the
medium was replaced.
LIPOFECTAMINETM was used according to the manufacturer's
instructions. Briefly, DNA and LIPOFECTAMINETM were added to
separate tubes of serum-free medium (MEM). The solutions were
then gently mixed together, and allowed to sit at room temperature
from 15-45 minutes, after which they were added to cells which had
been washed once with serum-free medium. After 2-6 hours,
complete medium was added to the dish, which was, In turn,
replaced with fresh medium 24 hours later.
3.5.1 8-galactosidase assays
DNA uptake was assayed using the reporter plasmid construct
pCMV-Bgal, carrying the structural gene for B-galactosidase, under
control of the cytomegalovirus (CMV) promoter. Forty-eight hours
after transfection, cell monolayers were fixed for 5 minutes in 4%
paraformaldehyde, pH 7.4. . Fixative was then removed by rinsing 3
times with IX phosphate-buffered saline (PBS), the second rinse
lasting 10 minutes. The chromogenic substrate X-gal (5-bromo-4-
chloro-3-indolyl-~-D-galactoside)was then added at a concentration
of 1 mg/ml, in a solution of 35mM K3Fe(CN)6, 35mM K4Fe(CN)6,
ImM MgCI2, in PBS. The cells were then incubated at 37 degrees for
2-24 hours, after which time cells expressing B-gal appeared blue.
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3.6 Microscopy
Cell counts for B-gal assays were performed under 100x
magnification, on a Telaval 3 microscope (Carl Zeiss, West Germany).
Stained cells were photogr~phed on a MC63 photo-micrographic
camera, mounted on a DRC stereo microscope (Carl Zeiss, West
Germany), under lOOx magnification. Non-adherent cells were
photographed by phase-contrast microscopy, using a phase-contrast
objective, 250x magnification.
3.7 Extraction of mammalian genomic DNA
Cells were lysed in lOmM tris, 10mM EDTA, 0.4% SDS, 50 ul/ug
pronase (Boehringer Mannheim), for 90 minutes at 37°C. The lysate
was then extracted three times with phenol/choroform, following
precipitation of DNA with 2 volumes ice-cold ethanol. The DNA was
resuspended in H20, and checked for purity by spectrophotometry at
A260 and A260/A280·
3.8 Southern blotting and hybridization
Genomic inserts were detected by the method of Southern
(1975) as modified by Ausubel et. ale (1992).
3.8.1 Transfer of DNA to nylon membrane
Genomic DNA was digested for 4-6 hours, followed by the
addition of loading buffer (5J.11/20J.11 digest). The samples were then
separated by agarose gel electrophoresis (0.8% agarose). Following
electrophoresis, the gel was stained with 0.5Jlg/ml EtBr and
photographed on a UV light source. The gel was then placed in
.1
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250mM HCI for 8 minutes, with gentle agitation. Following a brief
rinse in deionized water, the gel was immersed in 1.5M NaCI/O.5M
NaOH, for 2x15 minutes, with gentle rocking. During this step, a
nylon membrane (S&S), which was cut to fit the size of the gel, was
prepared by floating in deionized water until saturated, then placed
in O.5M NaOH for 5 minutes. A transfer container was set up by
placing a piece of 3MM Whatman paper in an electrophoresis box,
bridging the 2 reservoirs. After the Whatman paper was wetted
with 0.5N NaOH, the gel was inverted and placed on the paper. The
nylon membrane was then placed on top of the gel, and 2 more
pieces of 3MM Whatman paper placed over the membrane. A Scm
thick stack of paper towels was placed on top o~ the Whatman paper,
along with a O.2-0.4kg weight. After transfer was complete
(overnight), the nylon membrane was dri~d at room temperature.
The DNA was fixed to the membrane by applying UV radiation
(254nm) in a UV Stratalinker 1800 (Stratagene).
3.8.2 Radiolabeling of DNA probes
Radiolabeled DNA probes were synthesized by the method of
nick-translation, USIng a commercial nick-translation system
(Promega). For O.5J.lg of cesium chloride purified template DNA In a
25IJ-I reaction, the follow·ing components were added: 2.5IJ-I lOx
nick-translation buffer; 5IJ-I nucleotide mix (300IJ-M stock); 35IJ-Ci
a 32 P-dATP; 2.5IJ-I DNA polymerase I/Dnase I mix; nuclease-free
water to 25IJ-I. The reaction was then incubated at 15°C for 1 hour,
after which stop-solution (provided) was added. Prior to use, the
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reaction tube containing the probe wa~ placed In boiling water for 2
minutes.
3.8.3 Prehybridization, J hybridization and washing
The prehybridization, hybridization and washing was
performed at 68°C, in a Hybaid hybridization oven. Prior to
hybridization, the membrane was conditioned in a solution
containing 6xSSC, 5xDenhardt's reagent [50xDenhardt's reagent: 1%
Ficoll (Pharmacia); 1% polyvinylpyrrolidone; 1% bovine serum
albumin (Sigma)]; 0.5% SDS and 100Jlg denatured herring sperm
DNA (Gibco BRL), for 1 hour. Hybridization was performed overnight
in a solution of 6xSSC, 0.5% SDS, 100Jlg denatured herring sperm
DNA and labelled probe (approx. 0.2xl08 cpm). The membrane was
washed, following hybridization, for 15 minutes in 6xSSC, 0.5% SDS.
The membrane was then washed a second time in lxSSC, 0.5% SDS,
for 15 minutes, followed by a third was in O.IXSSC, 0.5% SDS, for 30
minutes.
The membrane was placed on a pIece of 3MM Whatman paper,
In an X-ray cassette containing a Cronex intensifying screen, covered
with plastic wrap and exposed to Kodak X-OMAT X-ray film for at
least 6 hours.
3.9 Extraction of cellular RNA
Mammalian cultures were lysed directly in the culture dish by
adding Iml TRIzOLTM reagent (Gibco BRL) to a 60mm dish. The
homogenate was transferred to a 1.5ml microcentrifuge tube, and
incubated for 5 minutes at room temperature. A volume of 0.2ml of
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chloroform was then added, followed by vIgorous shaking for 15
seconds, and 2-3 minutes incubation at room temperature. The
samples were then centrifuged at 12,000xg for 15 minutes.
or
Following centrifugation, the upper, aqueous phase was transferred
to a fresh tube, mixed with O.5ml isopropyl alcohol, and incubated at
room temperature for 10 minutes. The samples was then
centrifuged for 10 minutes at 12,000xg. Following removal of the
supernatant, the pellet was washed once with 75% ethanol, and
centrifuged at 7,500xg for 5 minutes. The supernatant was once
again removed, and the RNA was then stored as a precipitate in 70%
ethanol, or suspended in H20 and used immediately.
3.9.1 Northern blot and hybridization
Total RNA (30J..lg) was separated by electrophoresis In a 1%
agarose-formaldehyde gel [1 % agarose; Ix (20mM) MOPS (3-(N- .
morpholino) propanesulfonic acid); diethyl pyrocarbonate (DEPC)-
treated H20; 0.66M formaldehyde], for 4 hours at 0.5V/cm, using an
electrophoresis buffer of 10xMOPS/EDTA (0.2M MOPS; 50mM sodium
acetate; 10mM EDTA, pH 7.0). Prior to loading on the gel, the RNA
samples were added to electrophoresis sample buffer (O.75ml
formamide; 0.15ml lOx MOPS; 0.24ml formaldegyde; O.lml deionized
DEPC-treated water; O.lml glycerol; 0.08 ml 10% (w/v) bromophenol
blue). The RNA was transfered to a nylon membrane as described
for the Southern analysis above, but without soaking in HCI and
NaOH/NaCI,.and using 10xSSC as the transfer buffer.
Prehybridization, hybridization and washing were performed as
previously described.
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3.10 Immunoprecipitation of cellular proteins
Cells were plated at densities of 5x1oS /60mm culture dish, 24
hours prior to immunoprecipitation assays. The medium was then
replaced with methione-free medium (ICN) supplemented with L-
glutamine [glutamax™ (Gibco BRL)]. After 1 hour, the cells were
labelled with 35 S-methionine, which was added to the culture dish at
a concentration of 100 mCi/ml. The cells were incubated for 2 hours,
after which the medium was removed. The cells were then lysed by
addition of 1 ml RIPA buffer, containing the protease inhibitor
aprotinin™ (Sigma), for 10 minutes at 4°C. Cellular debris was
pelleted by microcentrifugation at 10,000g for 5 minutes, and the
supernatant transferred to a fresh tube. Rabbit polyclonal
antibodies, raised to the carboxy terminus of the 12S EIA product of
Ad2, and conjugated to agarose-protein A beads (Santa Cruz
Biotechnology, Santa Cruz, California), were then added, and the
samples placed on a rocking platform for 2 hours at 4°C.
Immunoprecipitate complexes were then collected by centrifugation
at 10,000g for 20 seconds, followed by removal of the supernatant
and washing with 1 ml ice-cold RIPA buffer. Centrifugation and
washing was repeated 3 more times, after which final traces of
buffer were removed with a pasteur pipette which had been
narrowed at the end in a flame. The pellets were then suspended In
50 ml of sample buffer (B-mercaptoethanol; glycerol), and stored at
-20°C until use. Immunoprecipitates were analysed by SDS-PAGE, in
a 10% polyacrylamide gel, including a low-molecular weight size
marker (BioRad). Prior to loading, the samples were denatured in
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boiling water for 5 minutes. Gels were soaked in 1M sodium
salicylate for 30 minutes, dried, and exposed to Kodak X-ray film for
10 days.
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CHAPTER 4: RESULTS
Two novel bovine cell lines were established over a series of
steps. First, the recombinant plasmid pKC-neo was constructed. This
plasmid was then used to transfect both MDBK and primary cells,
after which selection in G418 identified candidate cell lines. Two cell
lines, E61 and E24, were analysed for DNA content, revealing the
presence of the pKC-neo sequences in each of the cellular genomes.
The E61 cells seemed to be expressing E1 RNA transcripts, according
to Northern analysis. In addition, both cell types were examined for
the ability to take up exogenous DNA, at which the E24 line was
found to be particularly efficient.
Although conditions for primary bovine kidney cells were
optimized, these cells were. not used in the final experiments, due to
problems with maintaining a consistent culture.
4.1 Construction of recombinant plasmid pKC-n e 0
The plasmid pKC-neo was constructed according to the
following strategy, starting with pSV2-PK, pSV2-neo(mcs), and
pKCI9, as illustrated in figures 9 and 10. Briefly, the first step in the
construction of pKC-neo was the conversion of the unique PvuII site
in pSV2-PK, to KpnI, by digestion of pSV2-PK with PvuII, followed
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by addition of KpnI linkers and religation. The neor gene was then
taken from pSV2-neo(mcs) by digestion with BamHI and HindIII,
and placed between these same sites in pSV2-KK, to generate pSV2-
neoK.
The SV40 promoter and neor gene were then removed from
pSV2-neoK by digestion with KpnI, and inserted into the unique
KpnI site in pKCI9. The resulting plasmid, pKC-neo , containing the
left 19.7 % of the BAV3 genome and the neor gene from Tn5, was
confirmed by digestion with several informative restriction enzymes,
followed by separation of the fragments on a 0.9% agarose gel (figure
11). Note that the values for all restriction site positions, indicated in
bp, are approximations.
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Figure 9. Step 1 in the construction of plasmid pKC-neo. The
unique PvuII site in pSV2-PK was converted to a KpnI site,
generating pSV2-KK, after which the neomycin-resistance gene from
pSV2-neo(mcs) was inserted between the HindIII and BamHI sites of
pSV2-KK, to generate pSV2-neoK.
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Figure 10. Step 2 in the construction of plasmid pKC-neo. The SV40
and neomycin-resistance sequences were removed from pSV2-neoK
by digestion with KpnI, and inserted into the unique KpnI site of
plasmid pKCI9.
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Figure 11. Recombinant plasmid pKC-neo. (l\) Restriction map of
pKC-tleo. The shaded region represents the left 0-19.7% of the Bi\V3
genome. (B) Agarose gel analysis of restriction fragments of pKC-tleo,
generated by digestion with BamHI, EcoRI, HindIII, Kpnl, CiaI and
PstI, la11es 2-7, respecti vely. Lane wI contains a lambda marker
(HirldIII digest).
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4.2 Establishment of primary lung cell culture
Two weeks following disaggregation of male fetal calf tissue,
cultures of kidney and lung -' cells were established. Problems with
maintaining the culture of kidney cells, however, resulted in the
eventual termination of their use. The primary lung fibroblasts are
presented in the photographs in figure 12.
4.3 Optimization of transfection conditions
Prior to experimental transfections, the optimum conditions for
both methods, the calcium phosphate precipitation and the
polycationic lipid LIPOFECTAMINETM, needed to be established, not only
to identify the optimum conditions, but also to choose the most
effective method (figure 13). The calcium -phosphate method was
optimized in terms of DNA load in the precipitation event, a critical
parameter as described by Loyter et. ale (1982), whereas transfection
with LIPOFECTAMINETM was optimized in terms of LIPOFECTAMINETM
volume per culture dish, with toxicity being the limiting factor and,
therefore of. major consideration.
The method of calcium phosphate precipitation was optimized
In terms of DNA load, or the amount of DNA present in the
precipitation reaction, prior to addition to the culture dish. The
choice of 10, 20 and 30Jlg of total DNA was based on results by
Loyter et. ale (1982), which showed the optimum DNA load for
murine cells to lie at 20Jlg/ml CaP04.
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According to manufacturer's specifications, the optimum
amount of DNA within the tested range for LIPOFECTAMINETM was 2Jl,g
for a 35mm dish of NIH3T3 cells of 80% confluency, using 9Jl,1 of
lipofectamine. The ratio of 4.5Jl,1 LIPOFECTAMINETM to IJl,g plasmid
DNA was therefore chosen for the assay to determine the optimum
amount of LIPOFECTAMINETM for applications on the MDBK, prImary
lung and primary kidney cells. The optimum amounts of
LIPOFECTAMINETM and DNA were scaled up accordingly by surface
area, to accomodate the larger experimental culture dishes.
It was determined that LIPOFECTAMINETM was the most effective
method of DNA transfection, for all cell types, and that 20-40J.lI
LIPOFECTAMINETM/60mm culture dish was a sufficient amount for
efficienct DNA delivery, while keeping toxicity at a mInImum.
Each assay dish received an equal amount of reporter plasmid
DNA (2Jl,g/35mm dish). For the method of calcium phosphate
precipitation, the total amount of DNA was adjusted using herring
sperm DNA (Gibco).
4.4 Dose-response for selection in G418
The minimum concentration of 0418 required to eliminate non-
resistant cells within 10 days was determined for each cell type
(figure 14). Based on these results, 800Jl,g/ml and 400Jl,g/ml G418
was used to select resistant MDBK and primary lung cells,
respectively.
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FigLlre 12. Prill1ary boville IUI1g fibroblasts, CllltLlred fron1 fetal
bovine lllng tisslle (1 OOx n1agnificatioll).
(A)
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Figure 13. Optimization of transfection. Cells were transfected with
pCMV -~galt using calcium phosphate precipitation (A) and
lipofectamine (B). Efficiency of DNA uptake was expressed as
percentage of total cells expressing ~-gal (blue in presence of Xgal).
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Figure 14. Dose-response curve for G418 cytotoxicity. Cells were
seeded in triplicate at a density of 2xl04/35mm well. Response to
G418 was assayed by cell counts after 10 days exposure to G418,
which were then expressed as percentage of control counts, to
accomodate differences in density requirements for each cell type.
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4.5 Establishment and analysis of E61 cells
After three weeks under selection, all transfected MDBK cells in
all experimental and control plates died, except for those contained
in a single focus in dish E6. This focus was lifted from the dish by
the use of a sterile ring filled with versene (5 mM EDTA, 30mM NaCI,
KCI, Na2HP04, KH2P04, 10 mM glucose, H20), and transferred to a
fresh, 15mm well. The cells were designated E61, and were
eventually expanded into progressively larger culture dishes, and
maintained under 400J..Lg/ml G418 throughout the experiments.
The E61 genomic DNA was analysed by Southern hybridization
(figure 15). The DNA was digested by HindIII, then probed with the
nick-translation products of pKC-neo, labelled with 32p-dATP. As
controls, HindIII digests of pKC-neo and MDBK DNA were also probed
on the same membrane. The hybridization pattern resulting from
the pKC-neo digest was as expected, producing the 4 characteristic
bands of the HindIII digest. The probe did not hybridize to the
control MDBK digest.
Hybridization to several bands In the E61-digest lane revealed
the presence of an insert of pKC-neo into the E61 genome. The
pattern of hybridization to- the E61 digest indicated that the integrity
of the El region was maintained, as illustrated in figure 15(C), where
the relevent H indIII fragments, which produce signals in the
hybridization of figure 8B, are shown relative to a linear map of the
plasmid.
--1
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Figure 15. (A) Agarose gel electrophoresis of E61 and MDBK DNA.
Lanes 1 and 2 contain 20J.lg of E61 and MDBK genomic DNA,
respectively, digested with HindIII. Lane 3 contains lng of pKC-neo,
digested with HindIII. (B) Southern transfer of (A), followed by
hybridization with nick-translated 32 P-Iabelled pKC-n eo.
(C) Schematic diagram corresponding to the possible orientation of
the pKC-neo insert in 'the E61 genome.
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Starting from the left-end of the BAV3 genome (0%), the
fragments encompassing the BAV3 and SV40-neomycin-resistant
sequences have approximate"' lengths of 1695, 2350 and 5136bp, and
produced signals at these positions on the hybridization membrane.
Additional signals were produced at approximately 2000, 3500,
4000, 6000 and 7000bp. These signals were faint, relative to the
bands at 2350 and 5136bp, except for the band at approximately
4000bp, which had equal intensity. The presence of at least two of
these bands could be explained by HindIII sites in flanking genomic
regions. The remainder may be due to methylation of sites In a
subpopulation of the cells.
The RNA content of the E61 cells was analysed by Northern
hybridization of total cellular RNA (figure 16). The plasmid pKC19
was used as a probe, instead of pKC-neo, since pKC19 does not
contain the near sequences, and would therefore not detect the
transcripts from that region. The probe hybridized to the RNA from
the E61 and BAV3-infected MDBK cells (lanes 1 and 3, respectively),
but not to the RNA from the MDBK cells (lane 2).
A B
1 2 3
6 1
Figure 16. (A) Agarose gel electrophoresis of E61 and MDBK RNA.
Lanes 1 and 2 contain 30f1,g total RNA from E61 and MDBK cells,
respectively. Lane 3 contains 30J.lg total RNA from BAV3-infected
MDBK cells, - 8 hOllrs post-infection. (B) Northern transfer of (A),
followed by hybridization \vith nick-translated 32 P-labelled pKC 19.
'I
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4.6 Establishment and analysis of E24 cells
All of the primary lung cells, except for a single focus, died
after two weeks under selection. The single remaining focus did not
appear to expand under the selection conditions and, as a result,
selection was removed. The cells, designated E24, were expanded
into progressively larger culture dishes, and have been passaged 29
times, to date.
Southern analysis of the genomic DNA content of the E24 cells
IS shown in figure 17. The genomic DNA was digested with HindIII,
and probed with the nick-translation products of pKC-neo, labelled
with 32p-dATP. As controls, HindIII digests of pKC-neo and primary
lung DNA were also probed on the same membrane. The
hybridization pattern resulting from the pKC-neo digest was as
expected, producing the 4 characteristic bands of the H indIII digest.
The probe did not hybridize to the control lung digest.
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Figure 17. (A) Agarose gel electrophoresis of E24 and primary lung
DNA. Lane 1 contains lng. of pKC-l'ze@, digested with HindIII. Lanes
2 and 3 contain 20~g of primary lung and E24 genomic DNA,
respectively, digested with HindIII.(B) Southern transfer of (A),
followed by hybridizaiton with nick-translated 32 P-Iabelled pKC-neo.
Approximate fragment sizes are indicated in base-pairs (bp).
4.7 ImmuDoprecipitation
As an alternative to Northern analysis of E24 cells., cellular
lysates of E24, E61, primary~lung, MDBK, 293, and both BAV2 and
BAV3-infected MDBK cells were immunoprecipitated with O.5Jlg of
anti-Ad2 EIA rabbit polyclonal antibodies. Immunoprecipitation of
El products from the 293 cells should have produced bands ranging
from 35-53kDa, with predominant bands at 45-48.5kDa and 50-
52kDa (Rowe eta al., 1983; Yee and Branton, 1985). SDS-PAGE and
autoradiography of the immunoprecipitates, however, revealed
multiple bands in all sample lanes after 10 days exposure (figure
18).
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Figure 18. Imn1unoprecipitation of cellular proteins, USing O.5lJ-g of
anti-Ad2 EI polyclonal antibody. Lanes 1-7: E61, E24, lung, MDBK,
BAV2, BAY3, 293. An- unlabelled, low-range molecular weight
standard was used for size determination (BioRad), visualized by
stainiI1,g in Coon1assie blue R-250 dye. Expected band positions are
indicated by arrows.
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4.8 Morphology and growth properties of E24 cells
The E24 cells are shown in the photographs in figure 19a and, at
higher density, in19b. Cell monolayers were fixed and stained with
a combination of methanol, formaldehyde, and crystal violet stain.
The E24 cells have lost the extended processes characteristic of the
fibroblastic parental primary lung cells, appearing more trapezoidal
in shape. The growth of these cells seems to be limited by density
factors, being unable to grow as dense foci and beyond a monolayer.
The non-adherent nature of the E24 cells is shown in phase-
contrast microscopic images of E24 and primary lung cells (figure
20). The non-adherent E24 cells appear as light, rounded images, in
contrast to the dark, flat adherent cells. Fibroblasts transformed by
oncogenIc ras and by El of Ad12 are shown for comparison.
To demonstrate the viability of the non-adherent E24 cells, 2
ml of medium was removed from a 150mm dish containing an E24
monolayer, which had been plated 2 days earlier at a density of
5x 106 cells, and added to a 60mm dish, along with an additional 3 ml
of complete medium. The same was done for control plates of MDBK
and primary lung cells. The E24 cells adhered to the culture dish and
began to divide, whereas the control cells did not.
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Figllre 19a. Morpl10logy of primary lung (A) aI1d E24 (B) cells
(lOOx n1agnification).
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Figure 19b. Morphology of prin1ary lung (A) and £24 (B) cells
( lOOx magnification).
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Figllre 20. Non-adherellt properties of E24 cells. Non-adherent E24
cells are seen as rounded inlages (indicated by arrows) in (A),
whereas prin1ary Illng cells are shown in (B). For comparison,
fibroblasts transformed with oncogenic ras (C) (from Saltiel, 1995)
alld with Ad12-EIA+p55 (D) (fronl White and Cipriani, 1990), are
also shown.
j
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4.9 Evaluation of DNA-uptake
The efficiency of DNA uptake for E61 and E24 cells was
determined using both calcium phosphate precipitation and
LIPOFECTAMINETM (figure 21). Efficiency was calculated as the
percentage of cells expressing the B-galactosidase gene, carried on
the plasmid pCMV-Bgal. Cells which had taken up and were
expressing the Bgal construct turned blue in the presence of the
chromogenic substrate x-gal.
As shown in panels (A) and (B) of figure 14, 293 cells exhibited
the highest degree of DNA uptake (as high as 50-60%) for both
transfection methods. LIPOFECTAMINETM was the most effective
method for all cell types and, using either method, the E24 cells
exhibited a transfection efficiency resembling that of the parental
prImary cells, and much higher than that of the E61 or the MDBK.
cells.
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Figure 21. Evaluation of DNA uptake efficiency for E61 and E24 cells.
As with previous transfection assays, B-galactosidase expression was
used to assess DNA uptake for methods using calcium phosphate
precipitation (A) and lipofectamine (B). The plasmid pUC 19 was used
as a negative control, and did not result in a positive signal.
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CHAPTER 5: DISCUSSION
Selection for candidate cell lines was based on resistance to the
aminoglycoside G418. The gene encoding an aminoglycoside
phosphotransferase, a G418 inhibitor, was linked to the BAV3 E1
sequences in a recombinant plasmid construct, pKC-neo, which was
then introduced into MDBK and primary bovine lung cells. This
selection system was based on the pSV2-neo construct of Southern
and Berg (1982), which provides the advantage of positive selection
for transformants due to the selective advantage conferred on the
cells by the dominant drug-resistant phenotype. The approach was
used as a rapid and convenient method of selecting potential E1-
expressing cell lines, since integration of the G418-resistant gene into
the genome of a cell would quite possibly be accompanied by the
integration of the neighbouring BAV3 E1 sequences.
This pKC-neo construct was advantageous for the establishment
of integration, since the only mammalian origin of replication,
contained within the SV40 promoter sequences, requires expression
of the SV40 LT antigen (as found in COS cells) for replication to
commence, ensuring the absence of replication in most mammalian
cells, including the ones used in this project and, in doing so,
increased the likelihood of integration.
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It is a reasonable assumption that integration of the complete
BAV3 region contained in pKC-neo would result in proper expression
of the E1 products, considering that the construct was made to
include the upstream E1 regulatory regions, including the enhancer,
CAAT box and a TATA motif, as well as the CRE, which is a target of
ATF and AP-1 (Angel et. al., 1987; Engel et. al., 1988). Proper
splicing of the El transcripts would be expected, since eukaryotic
splicing signals have been highly conserved during evolution, and
primary transcripts from different species are readily recognized and
processed in heterologous mammalian cells.
Any absence of expression in cells containing an intact E1
region could possibly be the result of methylation of nucleotides In
upstream regulatory sequences, since control of expression by
specific patterns of methylation in these sequences has been
observed in transformed cells (Kruczek and Doerfler, 1983; Doerfler,
1991). In addition, failure of the translational machinery of the cell
to recognize the AUG codons in both reading frames could result in
the absence of an EIB protein product, as will be discussed shortly.
The location of integration of pKC-neo in the E61 genome seems
to have been in the region encompassing the bacterial origin of
replication in the pUC 19 sequences, as evident from the restriction
pattern observed from the Southern hybridization. The proposed
location of integration is consistent with observations that the origin
of replication on M13 phage genomes are sites of recombination
(Michel and Ehrlich, 1986), along with SV40 sequences which are
targets for insertion and excision of the SV40 provirus (Bullock et. al.,
1985). These regions are locations where illegitimate recombination
.\
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has been observed, an event whereby recombination occurs through
regions of very small (3-10 bp), if any, homology (Rubnitz and
Subramani, 1984; Nakano et. al., 1984). Such recombination events
are rare, relative to homologous recombination, and are generated by
enzymes normally associated with DNA replication and repair, such
as DNA polymerases and topoisomerases. The origin of replication
and short SV40 sequences contain targets for enzymes such as
topoisomerase I, DNA gyrase, DNA polymerase and topoisomerase II,
the latter of which affects illegitimate recombination between the
plasmid pBR322, containing the bacterial origin of replication, and
phage lambda (Michel and Ehrlich, 1986).
Recombination may be facilitated by the various enzymes even
In the absence of plasmid recombination. The phenomenon of
illegitimate recombination, and recombination in general, is believed
to be incidental to replication and repair. To assess the applicability
of these models to the insertional event in the generation of the E61
cell line, it would be worthwhile to rescue and clone the insert and
the flanking genomic regions for sequence analysis at the junctions,
to search for signs of a recombination event consistent with the
illegitimate events observed in previous studies (for a review of
illegitimate replication, se~ Crow and Dove, 1987).
The establishment of the E61 cells satisfied the first goal in the
construction of the desired cell line. Since the E61 cells were
maintained by selection in G418, it remained desirable to construct
an additional cell line based on the transformation, or at least the
immortalization, of primary bovine cells with the BAV3 E1 region.
Such a cell line would be maintained by selection on the basis of
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immortalization by E1, and would therefore remain under the
pressure of maintaining the integrity of the integrated BAV3
sequences, unlike the case of the MDBK derivatives, already derived
from an established cell line:
The problem with trying to establish a cell line from prImary
cells, however, was one of selection. If a distinctly transformed
phenotype was not conferred upon the cells by the E1 region of
BAV3, then the isolation of cells expressing El would require enough
passages, perhaps 50 or more, to eliminate the non-immortalized
parental primary cells. This basis for selection, however, would
assume at least immortalization by E1.
Establishment of the E24 cell line was the first step in
overcoming these obstacles. These cells, established from primary
bovine lung cells, contain an insert which includes the BAV3 E1
region. Although the expression and integrity of the E1 region needs
yet to be directly confirmed, the cells certainly exhibit a phenotype
distinctly different from the parental primary lung cells. The use of
positive selection to identify cells containing El will now allow
evaluation of the resulting ·phenotypic changes, assuming they were
conferred by expression of E1, and subsequently permit the design
of selective conditions for .the establishment of a cell line from
primary cells, without the need for a drug-resistance marker.
The most striking morphological change in the E24 cells, when
compared to the primary parental line, is the elimination of the
extended processes characteristic of primary fibroblasts, and the
reduction in focal adhesion events, particularly apparent In the
extensive prevalence of non-adherent cells, which resemble ras-
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transformed cells. If, in fact, the El sequences are being expressed
in these cells, the role of p19 of EIB in the disruption of intermediate
filament networks must be considered (White and Cipriani, 1989,
1990). As a result of this disruption, the detachment of the
intermediate filaments from the plasma membrane may alter the
organization of the cell surface, affecting cell-cell attachment and
growth regulation, changes which can promote anchorage-
independent growth and tumorigenicity (White and Cipriani, 1989).
Alternatively, based on similar phenotypes conferred by ras
(Ruley, 1983) and another membrane-associated kinase oncogene,
pp60v-src (Shalloway eta al., 1987), the disruption of the
intermediate filaments by p19 could alter the organization of the
plasma membrane or structural elements of the cytoplasm in such a
way as to affect signal transduction pathw.ays transmitting messages
from the cell surface to the nucleus.
Interestingly, the participation of p19 in the aberrant growth
properties of the E24 cells is questionable, when considering the
shape of these cells in comparison to fibroblasts which have been
transformed separately by EIA+EIB, EIA+pI9, and EIA+p55
combinations (White and Cipriani, 1990) (figure 22). This
comparison revealed a mo~p·hology which is specific to
transformation by the EIA+p55 combination, suggesting the absence
of p19. The selective expression of p55 could be explained by failure
of the translational machinery to recognize the p19 AUG codon in the
respective reading frame.
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Figure 22. Comparison of ~24 cells (D) with baby rat kidney
fibroblasts which have been transformed by combinations of (A)
E1A+EIB, (B) EIA+p19 and (C) EIA+p55 (White and Cipriani, 1990).
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Since the effects of p19 and p55 are additive (White and
Cipriani, 1990), the absence of either of these products could explain
the inability of the E24 cellJs to grow to high density and beyond a
monolayer, unlike fully transformed cells. In addition, cells which
have been transformed by EIA+p55 have a flattened, trapezoidal
shape, similar to E24 cells, whereas those transformed by E1A+p 19
have a spindle shape (figure 22(B,C)). Those cells transformed by
EIA and the complete EIB, on the other hand, exhibit combinations
of both phenotypes (figure 22(A)), a morphology which was not
apparent in the E24 cells (figure 22(D)).
In the absence of pI9, the non-adherent nature of the E24 cells
would have to be explained by a mechanism secondary to expression
of the remaining EI products. Phenotypic changes resulting from
phosphorylation cascades or the activation of cellular oncogenes, IS
characteristic of transformed cells, where phosphorylation of
tyrosine residues on the ~arboxy terminal of integrins can result In
the release of the integrin from the cytoskeletal actin filaments,
causing a subsequent release from the fibronectin and collagen
matrix on the surface of the culture dish (Lui and Pawson, 1994).
Incidentally, the rounding of cells due to phosphorylation of the
integrins is also observed -during mitosis, in which serine residues
are the targets.
Similarly, transformed cells generally produce less fibronectin
(Hynes, 1973), which normally links the extracellular collagen and
the integrins, resulting in recruitment of actin filament bundles
(stress fibers) to the focal adhesion contacts. Reduced production of
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fibronectin therefore would prevent the flattening of the cells
(Yamada, 1991). If culture dishes are first coated with a fibronectin-
rich substrate, or if the level of fibronectin builds up naturally over
time, then such transformed "cells will exhibit a greater frequency of
attachment and focal adhesion.
Based on the assumption that the E24 cells were rounded due
to transformation, yet still viable, an attempt was made to seed E24
cells from the medium of a culture dish containing these cells, two
days after plating. Although not quantified in terms of efficiency,
the seeding of the non-adherent cells was a successful demonstration
of the ability of those cells to eventually attach to the substrate and
undergo focal adhesion.
If expression of the El regIon is confirmed, then the E24 cell
line may represent the first demonstration -of transformation by the
otherwise putative transforming region of BAV3 in culture.
An attempt to detect and confirm expression of E1 products
was made using immunoprecipitation, using polyclonal antibodies
raised to the carboxy terminus of the 12S mRNA product from Ad2,
which should recognize the -E1A products produced from the 13S,
12S, lIS and lOS transcripts as well, since all share a common
carboxy terminus. The major 289R and 243R products of the 13S
and 12S transcripts should have theoretical molecular weights of
32kDa and 26kDa, respectively. Immunoprecipitation of these
products from AdS-infected cells, however, produces bands ranging
from 35-53kDa, with predominant bands at 45-48.5kDa and 50-
52kDa (Rowe et. al., 1983; Yee and Branton, 1985). The discrepancy
in size is likely due to extensive post-translational modification, since
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these proteins are highly phosphorylated in VlVO (Gaynor et. al.,
1982; Yee et. al., 1983; Yee and Branton, 1985). The result would be
the recovery of multiple products, ranging from 35 to 53 kDa, from
the 293 control cells.
The use of this assay to analyse the candidate cell lines was
based on the assumption that the human Ad polyclonals would
recognIze the BAV products. Since cross-reactivity was not
previously demonstrated, the assumption could only be based on the
extent of homology between the Ad2 and BAV3 E1 nucleotide
sequences (Zheng et. al., 1994). The use of the Ad polyclonals was
based primarily on their availability, and a demonstration of their
cross-reactivity would have been not only informative in terms of
the conservation of protein structure, but also would have been
valuable for designing further investigations.
The option of first demonstrating cross-reactivity by western
blot was of course an option, but immunoprecipitation should have
produced the same results' if performed with the proper antibody
titre, as could be established using 293 cells. In addition, the
possible low level of expression of this regulatory region in the
BAV3-infected cell controls may require a more sensitive assay, such
as immunoprecipitation.
A preferable alternative to immunoprecipitation would be an
assay which would directly address the functionality of E1 products
in the candidate cell lines. Reporter genes linked to the promoter for
the E2 DNA-binding protein (DBP) would satisfy this objective, since
the E1 products are necessary and strong activators of the E2
promoter. In addition, screening for any transforming functions of
8 1
the BAV sequences could be done by transferring the transfected cell
cultures directly to soft agar, whereby transformed clones could be
easily and readily separated from the cell population.
Regardless of whethe~r or not the El region is being expressed
In the E24 cell line, the apparent immortalizaiton of the primary lung
cells will permit the exploitation of their ease of transfection.
Considering that MDBK and E61 cells are rather refractive to
transfection, an attempt to develop a cell line from primary cells was
appropriate for the purpose of transfection efficiency alone. The
substitution of MDBK cells, the parent of E61 and a widely used
bovine cell line, is desirable, given the low level of DNA uptake and
recombination observed in these cells. The E24 cells may very well
prove to be a rather useful research tool.
The different efficiencies of transfection among the varIOUS cell
types used in this investigation could possibly be explained by
membrane lipid profiles (particularly in the application of
LIPOFECTAMINETM, a polycationic lipid) or perhaps even the
intracellular environment. Explanations are only speculative,
however, considering that ·the mechanism of DNA uptake for either
method has not been completely elucidated. The case remains,
nonetheless, that some cell· types are not very amenable to DNA
uptake.
Considering the ability of human Ads to transform cells in
culture, an alternative to the methods used to generate the novel cell
lines would be to infect a bovine culture with a human Ad, such as
AdS, or the highly oncogenic Ad12, whereby integration and
immortalization would result from the non-permissive nature of the
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infection. This approach would circumvent the need for subcloning
the E1 region and for optimization of transfection conditions. The
utility of the resulting cell line in the rescue of BAV vectors would
rely on the ability of the human Ad products to complement growth
of a BAV which, according to the results of the transactivation
experiment of Zheng et. al. (1994) mentioned earlier, would be
expected. One advantage of such a cell line would be the possible
reduction of recombination between a mutant virus and the cellular
genome, resulting in reversion to wild-type, as has been a problem
with the human Ad and 293 cell line system.
Even if either the E61 or the E24 cells are expressIng functional
E1 products capable of complementing a BAV E1 deletion, it may still
be necessary to develop additional cell lines, more efficient in terms
of viral rescue, in light of the observation ~hat overexpression of E1A
products can inhibit viral replication (Adami and Babiss, 1990). It is
therefore important to assess the level of El expression within the
cells, and identify a candidate capable of efficient complementation
and rescue. The inclusion of specific promoters to drive transcription
of the El region may be a- reasonable approach to addressing any
problems involving levels of expressIon.
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SUMMARY
Based on the results obtained In this experiment, the following
conclusions can be stated:
(1) The left 0-19.7% of the BAV3 genome has been linked to the
neomycin-resistance gene of Tn5, in a construct designated pKC-neo.
(2) The construct pKC-neo has been inserted into the genome of
MDBK cells, generating the cell line E61, in such a way as to preserve
the integrity of the BAV3 E1 sequences.
(3) The E61 cells seem to be transcribing the E1 region, as detected
by Northern analysis of total RNA.
(4) The construct pKC-neo has also been inserted into the genome of
primary bovine lung cells, generating the E24 cell line, but the
orientation has not been confirmed.
(5) The E24 cells exhibit a morphology and growth property
different from their parental cells and characteristic of transformed
cells. They have lost the extended processes characteristic of
primary fibroblasts, and they exhibit non-adherent properties.
(6) The E24 cells may represent the first demonstration of the
transforming properities of the E1 region of BAV3 in culture.
(7) The E24 cells are effici.ent for the uptake of exogenous DNA, as
compared to the MDBK cell line.
(8) The E24 cells may be a new cell line with potential for valuable
applications to BAV research.
(9) Both the E61 and the E24 cell lines are candidates for the
complementation and rescue of BAV mutants.
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